If These Are The Best Pot Stocks...
Investing.com | Mar 15, 2022 08:16
In the world of cannabis stocks, there have been few real winners of late. The sector, on both sides of the Canada-US border, faces a number of challenges. So where is the money in the sector going?
Last month, US News and World Report published a list of the “Best Marijuana Stocks To Buy For 2022.” The article noted that the Biden presidency, "has been a major disappointment for cannabis stock investors." The piece pointed out that this frustration stems from, "virtually no progress on federal marijuana reform or legalization."
That said, let’s take a look at how the top five stocks in the piece have fared so far this year. Be warned: Brace yourselves.
h2 OrganiGram Holdings/h2OrganiGram Holdings (NASDAQ:OGI) (TSX:OGI) is a Canadian-based producer that serves both the medicinal and adult recreation markets.
On Feb. 18, the stock closed at US$1.53. At that time, Cantor Fitzgerald had an “overweight” rating on the stock and a US$4.18 price target.
Yesterday, OrganiGram shares closed at US$1.30, down about 3% on the day, and 9.7% since the beginning of March. And in the last year, they have lost almost 70% of their value.
Cresco Labs (OTC:CRLBF) (CSE:CL) is a US-based grower that operates in 10 states and owns more than 1,000 marijuana dispensary outlets.
On Feb. 18, the stock closed at US$7.44. Cantor Fitzgerald had an “overweight” rating on the stock and a US$19 price target at that time.
Yesterday, Cresco shares closed at US$5.54, flat on the day, and down about 15.3% since the beginning of March. In the last year, the stock has lost just over 58% of its value.
Curaleaf Holdings (OTC:CURLF) (CSE:CURA) is another US-based multi-state cannabis grower, but with a much bigger geographical footprint than Cresco. It operates in 23 states. And with annual sales of about US$1.3 billion, it is ranked the second largest multi-state operated company in the US.
Get The App
On Feb. 18, the stock closed at US$8.59. At that time, Cantor Fitzgerald had an “overweight” rating and a price target of US$16.50 on the stock.
Yesterday, Curaleaf shares closed at US$5.75, down 2.8% on the day, and down 9.87% since the beginning of March. In the last year, the stock has lost just shy of 63% of its value.
Green Thumb Industries (OTC:GTBIF) (CSE:GTII) is another US-based multi-state cannabis producer that operates in 14 of the country’s largest markets, with plans to expand.
On Feb. 18, the stock closed at US$21.27. And at that time Cantor Fitzgerald had an “overweight” rating on the stock and a price target of US$54.
Yesterday, Green Thumb closed at US$15.20, down 2.63% on the day, and down 15.5% since the beginning of March. In the last year, the stock has lost just over 54% of its value.
Trulieve Cannabis Corp (OTC:TCNNF) (CSE:TRUL) is a Florida-based pot grower with 112 dispensaries and a major player in the state’s medical marijuana market. It also operates in other states, including Massachusetts, Pennsylvania, and Arizona.
On Feb. 18, the stock closed at US$23.72. And at that time Cantor Fitzgerald had an “overweight” rating and a price target of US$72.
Yesterday, Trulieve closed at US$17.24, down about 7% on the day, and just over 16% since the beginning of March. In the last year, the stock has lost more than 62% of its value.
Still wondering where the money in the sector is going? Look for the puff of smoke.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.